Cvs Health (CVS) Change in Receivables (2009 - 2026)

Cvs Health's Change in Receivables history runs 18 years deep, the most recent figure standing at $94.2 billion for Q1 2026.

• Quarterly Change in Receivables rose 3.74% year-over-year to $94.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 billion (down 98.48% YoY) and the FY2025 annual result came in at $3.5 billion, down 99.02% from the prior year.
• Change in Receivables was $94.2 billion for Q1 2026 at Cvs Health, up from -$279.9 billion in the prior quarter.
• Across five years, Change in Receivables topped out at $267.3 billion in Q3 2024 and bottomed at -$279.9 billion in Q4 2025.
• A 5-year average of $27.3 billion and a median of $77.6 billion in 2022 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2022 — Change in Receivables sank 28916.73% — and 2025, when it surged 45467.14%.
• Cvs Health's Change in Receivables stood at -$232.4 billion in 2022, then slipped by 9.3% to -$254.0 billion in 2023, then surged by 136.79% to $93.5 billion in 2024, then tumbled by 399.47% to -$279.9 billion in 2025, then jumped by 133.66% to $94.2 billion in 2026.
• Business Quant data shows CVS's Change in Receivables at $94.2 billion in Q1 2026, -$279.9 billion in Q4 2025, and $96.9 billion in Q3 2025.